Pages that link to "Q35641868"
Jump to navigation
Jump to search
The following pages link to RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini (Q35641868):
Displaying 50 items.
- Progestin effects on cell proliferation pathways in the postmenopausal mammary gland (Q21092903) (← links)
- RANK-RANKL signalling in cancer (Q26747442) (← links)
- Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences (Q26863493) (← links)
- Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal Women (Q28077637) (← links)
- Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab (Q28265584) (← links)
- RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis (Q28294501) (← links)
- The RANKL signaling axis is sufficient to elicit ductal side-branching and alveologenesis in the mammary gland of the virgin mouse (Q28585870) (← links)
- Progesterone receptor isoform functions in normal breast development and breast cancer (Q33693898) (← links)
- Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. (Q33733718) (← links)
- Cellular microenvironment influences the ability of mammary epithelia to undergo cell cycle (Q33867450) (← links)
- Signal transducer and activator of transcription 5a mediates mammary ductal branching and proliferation in the nulliparous mouse (Q33874455) (← links)
- TNFRSF11A and TNFSF11 are associated with age at menarche and natural menopause in white women (Q34126306) (← links)
- Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. (Q34281611) (← links)
- Antibody-mediated "universal" osteoclast targeting platform using calcitonin as a model drug. (Q34774678) (← links)
- A local basis for progesterone action during mammary tumorigenesis - no longer RANK and file (Q35029498) (← links)
- Association of cellular and molecular responses in the rat mammary gland to 17β-estradiol with susceptibility to mammary cancer (Q35058926) (← links)
- From the ranks of mammary progesterone mediators, RANKL takes the spotlight (Q35686326) (← links)
- Aberrant Activation of the RANK Signaling Receptor Induces Murine Salivary Gland Tumors (Q35659971) (← links)
- Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity (Q35853244) (← links)
- The biology of progesterone receptor in the normal mammary gland and in breast cancer (Q35868802) (← links)
- Progestin-regulated luminal cell and myoepithelial cell-specific responses in mammary organoid culture (Q36578851) (← links)
- Identification of novel human receptor activator of nuclear factor-kB isoforms generated through alternative splicing: implications in breast cancer cell survival and migration (Q36924500) (← links)
- Impact of denosumab on bone mass in cancer patients (Q37000157) (← links)
- Prolactin regulation of mammary gland development. (Q37064933) (← links)
- Mammary involution and breast cancer risk: transgenic models and clinical studies (Q37220983) (← links)
- Role of RANKL/RANK in primary and secondary breast cancer (Q37241255) (← links)
- Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines (Q37356654) (← links)
- Osteoimmunology: crosstalk between the immune and bone systems (Q37544448) (← links)
- Pubertal high fat diet: effects on mammary cancer development. (Q37690070) (← links)
- The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma. (Q37745788) (← links)
- RANKL inhibition: a promising novel strategy for breast cancer treatment. (Q37865171) (← links)
- The NFκB pathway: a therapeutic target in glioblastoma (Q37928304) (← links)
- Denosumab and the current status of bone-modifying drugs in breast cancer (Q37965768) (← links)
- Antiresorptive therapies in oncology and their effects on cancer progression (Q37988707) (← links)
- Targeting RANKL in breast cancer: bone metastasis and beyond (Q38081245) (← links)
- Progesterone signalling in breast cancer: a neglected hormone coming into the limelight (Q38109029) (← links)
- Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells (Q38373935) (← links)
- Progestogens and risk of breast cancer: a link between bone and breast? (Q38572022) (← links)
- Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort (Q38682103) (← links)
- RANK as a therapeutic target in cancer. (Q38691526) (← links)
- Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage. (Q38764888) (← links)
- RANK-RANKL interactions are involved in cell adhesion-mediated drug resistance in multiple myeloma cell lines (Q38804090) (← links)
- RANK expression on breast cancer cells promotes skeletal metastasis (Q39055979) (← links)
- Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis. (Q39214999) (← links)
- RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis (Q39365550) (← links)
- Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis (Q40038407) (← links)
- Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis. (Q42439949) (← links)
- Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation. (Q42486557) (← links)
- Stem cells: Cues from steroid hormones (Q43036665) (← links)
- Control of mammary stem cell function by steroid hormone signalling. (Q43103606) (← links)